Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Inactivated Influenza A/H5N1 Vaccine Administered Intradermally With or Without Topical Aldara in Healthy Young Adults

Conditions:   Avian Influenza;   Influenza Immunisation Interventions:   Other: Aqueous Cream B.P.;   Drug: Imiquimod;   Biological: Influenza Virus Vaccine, Monovalent A/H5N1 A/Vietnam/1203/04 Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials